These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35883526)

  • 1. COVID-19 and Parkinsonism: A Critical Appraisal.
    Cavallieri F; Fioravanti V; Bove F; Del Prete E; Meoni S; Grisanti S; Zedde M; Pascarella R; Moro E; Valzania F
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID parkinsonism: A scoping review.
    Polverino P; Cocco A; Albanese A
    Parkinsonism Relat Disord; 2024 Jun; 123():106066. PubMed ID: 38480080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viruses, parkinsonism and Parkinson's disease: the past, present and future.
    Leta V; Urso D; Batzu L; Lau YH; Mathew D; Boura I; Raeder V; Falup-Pecurariu C; van Wamelen D; Ray Chaudhuri K
    J Neural Transm (Vienna); 2022 Sep; 129(9):1119-1132. PubMed ID: 36036863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients.
    Morassi M; Palmerini F; Nici S; Magni E; Savelli G; Guerra UP; Chieregato M; Morbelli S; Vogrig A
    J Neurol; 2021 Nov; 268(11):3980-3987. PubMed ID: 33884450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19.
    Mancini M; Natoli S; Gardoni F; Di Luca M; Pisani A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post COVID-19 disorders: is the epidemic of parkinsonism threatening the world?].
    Damulin IV; Strutzenko AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):22-28. PubMed ID: 36168684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covid-19 Infection and Parkinsonism: Is There a Link?
    Bouali-Benazzouz R; Benazzouz A
    Mov Disord; 2021 Aug; 36(8):1737-1743. PubMed ID: 34080714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines.
    Dulski J; Sławek J
    Neurol Neurochir Pol; 2023; 57(1):53-62. PubMed ID: 36799523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson disease following COVID-19: Report of six cases.
    Calculli A; Bocci T; Porcino M; Avenali M; Casellato C; Arceri S; Regalbuto S; Priori A; Pisani A
    Eur J Neurol; 2023 May; 30(5):1272-1280. PubMed ID: 36807419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism associated with viral infection.
    Ivan I; Irincu L; Diaconu Ş; Falup-Pecurariu C
    Int Rev Neurobiol; 2022; 165():1-16. PubMed ID: 36208896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far.
    Boura I; Chaudhuri KR
    Mov Disord Clin Pract; 2022 Jul; 9(5):584-593. PubMed ID: 35601258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism.
    Vignatelli L; Zenesini C; Belotti LMB; Baldin E; Bonavina G; Calandra-Buonaura G; Cortelli P; Descovich C; Fabbri G; Giannini G; Guarino M; Pantieri R; Samoggia G; Scaglione C; Trombetti S; D'Alessandro R; Nonino F;
    Mov Disord; 2021 Jan; 36(1):1-10. PubMed ID: 33196119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns.
    Phokaewvarangkul O; Virameteekul S; Bhidayasiri R
    Parkinsonism Relat Disord; 2021 Jun; 87():39-40. PubMed ID: 33940565
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.
    Boura I; Qamar MA; Daddoveri F; Leta V; Poplawska-Domaszewicz K; Falup-Pecurariu C; Ray Chaudhuri K
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease.
    Zhang J
    Front Neurol; 2022; 13():968193. PubMed ID: 36570463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism in viral, paraneoplastic, and autoimmune diseases.
    Xing F; Marsili L; Truong DD
    J Neurol Sci; 2022 Feb; 433():120014. PubMed ID: 34629181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.